FTC OKs Novartis' $1.5B Fougera Buy With Divestitures
The Federal Trade Commission on Monday approved Novartis AG's $1.5 billion purchase of dermatology treatment specialist Fougera Holdings Inc. from several private equity funds, after the drugmaker agreed to give up...To view the full article, register now.
Already a subscriber? Click here to view full article